tirzepatide kidney damage (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Effects of tirzepatide versus insulin

taking it with food reduces this risk

Hemoglobin A1C decreased by -2.34% when tirzepatide was taken at the maximum dose of 15 mg per week

Key research findings include: Weight loss attributed to green tea in clinical trials averages 0.23.5 kg over 12 weeksmodest compared to lifestyle interventions Effects appear more pronounced in some studies with participants of Asian descent, possibly due to genetic differences in caffeine and catechin metabolism, though these findings are confounded by differences in habitual caffeine intake and other factors Green tea may be more effective when combined with exercise, potentially enhancing fat oxidation during physical activity Long-term sustainability of metabolic effects remains uncertain, with some evidence suggesting adaptation over time It is crucial to recognise that green tea is not a substitute for evidence-based weight management strategies

What should I do if I used insulin that was left out too long

The risk of hypoglycemia increases during periods of reduced food intake

"Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes"